It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Berardinelli–Seip congenital lipodystrophy (CGL), a rare autosomal recessive disorder, is characterized by a lack of adipose tissue. Infections are one of the major causes of CGL individuals’ premature death. The mechanisms that predispose to infections are poorly understood. We used Leishmania infantum as an in vitro model of intracellular infection to explore mechanisms underlying the CGL infection processes, and to understand the impact of host mutations on Leishmania survival, since this pathogen enters macrophages through specialized membrane lipid domains. The transcriptomic profiles of both uninfected and infected monocyte-derived macrophages (MDMs) from CGL (types 1 and 2) and controls were studied. MDMs infected with L. infantum showed significantly downregulated expression of genes associated with infection-response pathways (MHC-I, TCR-CD3, and granzymes). There was a transcriptomic signature in CGL cells associated with impaired membrane trafficking and signaling in response to infection, with concomitant changes in the expression of membrane-associated genes in parasites (e.g. δ-amastins). We identified pathways suggesting the lipid storage dysfunction led to changes in phospholipids expression and impaired responses to infection, including immune synapse (antigen presentation, IFN-γ signaling, JAK/STAT); endocytosis; NF-kappaB signaling; and phosphatidylinositol biosynthesis. In summary, lipid metabolism of the host plays an important role in determining antigen presentation pathways.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details








1 Federal University of Rio Grande do Norte, Health Sciences Center, Natal, Brazil (GRID:grid.411233.6) (ISNI:0000 0000 9687 399X); Institute of Tropical Medicine of Rio Grande do Norte, Natal, Brazil (GRID:grid.411233.6)
2 Institute of Tropical Medicine of Rio Grande do Norte, Natal, Brazil (GRID:grid.411233.6)
3 Institute of Tropical Medicine of Rio Grande do Norte, Natal, Brazil (GRID:grid.411233.6); Federal University of Rio Grande do Norte, Department of Biochemistry, Natal, Brazil (GRID:grid.411233.6) (ISNI:0000 0000 9687 399X)
4 University of Iowa and the Veterans’ Affairs Medical Center, Departments of Internal Medicine and Microbiology & Immunology, Iowa City, USA (GRID:grid.484403.f) (ISNI:0000 0004 0419 4535)
5 Onofre Lopes University Hospital, Department of Clinical Medicine, Natal, Brazil (GRID:grid.484403.f)
6 Federal University of Rio Grande do Norte, Health Sciences Center, Natal, Brazil (GRID:grid.411233.6) (ISNI:0000 0000 9687 399X); Institute of Tropical Medicine of Rio Grande do Norte, Natal, Brazil (GRID:grid.411233.6); Federal University of Rio Grande do Norte, Department of Biochemistry, Natal, Brazil (GRID:grid.411233.6) (ISNI:0000 0000 9687 399X)